Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exicure, Inc. - Common Stock (NQ:XCUR)

4.880 -0.120 (-2.40%)
Streaming Delayed Price Updated: 10:13 AM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exicure, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Exicure Stock Plunges After Results Of Internal Probe, Management Shakeup, Layoffs
Exicure Inc's (NASDAQ: XCUR) Audit Committee concluded that Grant Corbett misreported raw data from certain R&D experiments related to XCUR-FXN preclinical... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Arena Pharmaceuticals (NASDAQ:ARNA... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2021
Upgrades According to B of A Securities, the prior rating for Globus Medical Inc (NYSE: 
Via Benzinga
EXICURE SHAREHOLDER NOTICE
 
Via NewMediaWire
Topics Regulatory Compliance
EXICURE UPDATE
Via NewMediaWire
Topics Regulatory Compliance
EXICURE SHAREHOLDER NOTICE
Via NewMediaWire
Topics Regulatory Compliance
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Arena Pharmaceuticals (NASDAQ:ARNA) stock moved upwards by 91.22% to $95.5 during Monday's pre-market session. The company's market cap stands at $5.8... 
Via Benzinga
EXICURE UPDATE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus
From Exicure, Inc.
Via Business Wire
EXICURE SHAREHOLDER ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
EXICURE UPDATE
Via NewMediaWire
Topics Regulatory Compliance
EXICURE INVESTOR ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exicure, Inc. (NASDAQ:XCUR) Investor Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 12/07/2021 -- Exicure, Inc is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Topics Regulatory Compliance
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
EXICURE SHAREHOLDER ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
EXICURE INVESTOR ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
EXICURE INVESTOR ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers XTL Biopharmaceuticals (NASDAQ:XTLB 
Via Benzinga
EXICURE SHAREHOLDER NOTICE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
EXICURE SHAREHOLDER ALERT
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Exicure To Contact Him Directly To Discuss Their Options 
Via NewMediaWire
Topics Regulatory Compliance
EXICURE ALERT: Bragar Eagel & Squire, P.C. is Investigating Exicure, Inc. on Behalf of Exicure Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
EXICURE INVESTOR ALERT
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Exicure To Contact Him Directly To Discuss Their Options 
Via NewMediaWire
Topics Regulatory Compliance
EXICURE SHAREHOLDER ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
EXICURE SHAREHOLDER ALERT
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ExicureTo Contact Him Directly To Discuss Their Options 
Via NewMediaWire
Topics Regulatory Compliance
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares... 
Via Benzinga
Exicure's Return on Invested Capital Overview
Benzinga Pro data, Exicure (NASDAQ:XCUR) reported Q3 sales of $-3.68 thousand. Earnings fell to a loss of $23.08 million, resulting in a 66.51% decrease from last quarter. In Q2... 
Via Benzinga
Exicure, Inc. Reports Third Quarter 2021 Financial Results and Corporate Progress
From Exicure, Inc.
Via Business Wire
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.